Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 17 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • The source record leaves some stereochemistry unspecified. This calculated conformer does not establish a unique stereoisomer.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C12H15N3O2
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer

Phenylpiracetam Hydrazide

Nootropics

Published formats

  • Dry-Fill Capsule 120ct/100mg/12g
  • Powder 5g
What is the difference between these?
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number77472-71-0
Molecular FormulaC₁₂H₁₅N₃O₂
Molecular Weight233.27 g/mol
IUPAC Designation2-(2-oxo-4-phenylpyrrolidin-1-yl)acetohydrazide
Physical FormWhite to off-white crystalline powder
Storage RequirementsRefer to product documentation
Other NamesFonturacetam Hydrazide, 1-Pyrrolidineacetic acid, 2-oxo-4-phenyl-, hydrazide
Capsule Concentration100mg x 120ct
Bulk Powder Quantity5g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Phenylpiracetam Hydrazide Research Standard

Phenylpiracetam Hydrazide (Fonturacetam Hydrazide) is a synthetic analog of the racetam-class compound phenylpiracetam. By substituting the terminal amide group with a hydrazide moiety, this compound differs from its parent scaffold at the position that governs hydrolytic behavior. In laboratory research, it is utilized as a specialized probe for investigating the structure-activity relationships (SAR) of the racetam class, metabolic stability, and the modulation of neural signaling pathways in in vitro models.

Physical & Handling Properties

Property Specification
Physical Appearance White to off-white crystalline powder

Mechanism of Action & Research Context

The primary research interest in Phenylpiracetam Hydrazide lies in its modified chemical structure, which distinguishes it from traditional amide-based racetams.

  • Hydrazide Modification: The incorporation of the hydrazide group into the racetam scaffold is hypothesized to influence the compound's metabolic rate and shelf-life. This allows researchers to study how varying the terminal functional group affects chemical stability in various aqueous and organic solvents.

  • Permeability and Interaction: Like other phenylated racetams, the compound is utilized to investigate the modulation of neural signaling and synaptic plasticity. The hydrazide modification serves as a control variable in SAR studies to determine how this specific moiety impacts ligand interaction with neurotransmitter pathways.

  • Metabolic Studies: Because the hydrazide bond has different hydrolytic characteristics than the parent amide, it is frequently used to study the decomposition and structural integrity of racetam derivatives under diverse environmental conditions.

Research Applications

Phenylpiracetam Hydrazide is a foundational reference material for neuropharmacology and analytical chemistry.

Primary fields of in vitro laboratory investigation include:

  • Cellular Bioenergetics: Observing changes in neuronal energy utilization and metabolic demand in response to the compound.

  • Structure-Stability Research: Analyzing the longevity of the hydrazide bond across various pH and temperature ranges compared to standard amide-based racetams.

  • Neural Signaling Models: Investigating the modulation of neurotransmitter systems (such as cholinergic or glutamatergic pathways) in cultured neuronal networks.

  • Chromatographic Benchmarking: Serving as a pure reference standard for developing HPLC separation protocols for racetam-class compounds and their derivatives.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

References

  • Malykh AG, Sadaie MR. (2010) "Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders." Drugs. 70(3): 287–312. (Contextual background on the racetam class).

  • Note: As Phenylpiracetam Hydrazide is a synthetic derivative, refer to lot-specific Certificate of Analysis (COA) data for precise analytical validation reports.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.